Business Context and Reporting Period
Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 10, 2024
Reporting Period: Preliminary financial results for the quarter and fiscal year ended December 31, 2023.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This Form 8-K serves solely as a notice that a press release containing these preliminary results has been issued and is attached as Exhibit 99.1.
Material Changes
No material changes or comparative financial data are detailed within the body of this filing. The document references the attached press release for specific operational and financial updates.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on January 10, 2024, announcing preliminary results.
Legal Disclaimer: The information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section. It shall not be deemed incorporated by reference in any other filing unless expressly set forth by specific reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated January 10, 2024) for actual revenue, profit, and cash flow figures.
- Verify the specific details of the preliminary results for the quarter and fiscal year ended December 31, 2023.
- Confirm whether the preliminary results have been updated in subsequent filings (e.g., Form 10-Q or 10-K).